New service available

Read more


Flexibility to expand from panel to exome in 14 medical specialties.


Webinar on immune-related disorders



Join our webinar on Oct 25th on the utility of genetic testing and application to immune-related disorders.


Easy ordering and networking platform for clinicians

Read more about Nucleus

“The genetic services of Blueprint Genetics were highly professional. Their results came in due time, together with a thorough and insightful interpretation, reflecting high professional standards. We were very pleased with this collaboration and wish to continue it.”

Dr. R.Jurcut cardiologist, cardiomyopathy expert


A Finnish study finds evidence indicating the JPH2 gene to be causative in hypertrophic cardiomyopathy

Published on September 21, 2018

This study1 provides the first substantial evidence of the JPH2 gene associating with monogenic familial hypertrophic cardiomyopathy (HCM). The study ‘Heterozygous Junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure’ was published recently in PLOS ONE. Hypertrophic cardiomyopathy is considered the most common form of inherited cardiomyopathies,…

Read more

See all news


Kardiologisk Høstmøte 2018

Martin Linges Vei 2, Fornebu, Norway

The autumn Kardiologisk Høstmøte meeting will be held at Scandic Fornebu 25th-27th October in Norway. A varied and exciting program is in place with national and international speakers for this meeting. The program will be relevant to anyone with an interest in cardiology – regardless of profession, regardless of age and…

Read more

See all events


Blueprint Genetics is a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory. Our Sequence Analysis is ISO 15189  accredited in every step from sample arrival to clinical interpretation. The ISO 15189 standard accreditation is carried by FINAS and the information about the scope is available on the website www.finas.fi/Documents/T292_A01_2016.pdf.   Read more

Get our latest updates directly to your mailbox.